Global Drug Repositioning Service Market Report 2025

Report Price : $4490.00

Pages :

Format : PDF

Published : November 2025

Delivery Time : 2-3 Business Days

Purchase This Report

Drug Repositioning Service Global Market Report 2025

Name: Drug Repositioning Service Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Type (Generic Drugs, Clinical Trial Failed Drugs), By Therapeutic Area (Oncology, Neurology, Infectious Diseases, Cardiovascular Diseases, Other Therapeutic Area), By End-User (Pharmaceutical Companies, Biotechnology Firms, Contract Research Organizations (CROs), Academic Research Institutions, Hospitals And Ambulatory Surgical Centers.) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Drug Repositioning Service Market Overview

• Drug Repositioning Service market size has reached to $32.34 billion in 2024

• Expected to grow to $43.26 billion in 2029 at a compound annual growth rate (CAGR) of 6.1%

• Growth Driver: Surge In Rise In Healthcare Expenditures Fueling The Growth Of The Market Due To Increasing Medical Costs

• Market Trend: AI-Enabled Drug Repositioning Project

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Drug Repositioning Service Market?

The main types of drug repositioning service are generic drugs, and clinical trial failed drugs. Generic drugs are medications that have the same active ingredients, strength, dosage form, and therapeutic effect as brand-name drugs but are typically sold at lower prices. The various therapeutic area include oncology, neurology, infectious diseases, cardiovascular diseases, other therapeutic area. These are used by various end users such as pharmaceutical companies, biotechnology firms, contract research organizations (CROs), academic research institutions, hospitals and ambulatory surgical centers.

Drug Repositioning Service Market Size and growth rate 2025 to 2029: Graph

What Is The Drug Repositioning Service Market Growth Forecast?

The drug repositioning service market size is expected to see strong growth in the next few years. It will grow to $43.26 billion in 2029 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to Increasing prevalence of chronic and complex diseases, continued advancements in AI and machine learning, growing focus on personalized medicine, expansion of global healthcare access, strengthening of intellectual property protections for repurposed drugs, collaborations between pharmaceutical companies and research institutions. Major trends in the forecast period include rising demand for cost-effective drug development, expansion of data-driven repurposing platforms, focus on rare and complex diseases, steady market growth across major regions, regulatory support for repositioning strategies, and increasing investment in predictive analytics and real-world data integration.

What Is The Drug Repositioning Service Market Size 2025 And Growth Rate?

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Drug Repositioning Service Market Segmented?

1) By Type: Generic Drugs, Clinical Trial Failed Drugs

2) By Therapeutic Area: Oncology, Neurology, Infectious Diseases, Cardiovascular Diseases, Other Therapeutic Area

3) By End-User: Pharmaceutical Companies, Biotechnology Firms, Contract Research Organizations (CROs), Academic Research Institutions, Hospitals And Ambulatory Surgical Centers.

Subsegments:

1) By Generic Drugs: Small Molecule Drugs, Biologics, biosimilars, Peptide-Based Drugs

2) By Clinical Trial Failed Drugs: Phase I Failed Drugs, Phase II Failed Drugs, Phase III Failed Drugs, Safety-Related Failed Drugs, Efficacy-Related Failed Drugs.

What Is Driving The Drug Repositioning Service Market? Surge In Rise In Healthcare Expenditures Fueling The Growth Of The Market Due To Increasing Medical Costs

The rise in healthcare expenditures is expected to propel the growth of the drug repositioning service market going forward. Healthcare expenditures refer to the total funds spent on health services, including prevention, treatment, rehabilitation, and administration. Healthcare expenditures are rising primarily due to increasing medical costs driven by technological advancements and the growing demand for healthcare services. Higher healthcare expenditure benefits drug repositioning services because increased funding allows for more clinical trials and research, accelerating the identification of new therapeutic uses for existing drugs. For instance, in March 2022, according to the 2021–2030 National Health Expenditure (NHE) report published by the Centers for Medicare & Medicaid Services, a US-based federal agency, the projected growth indicates that, on average, national health spending is expected to increase by 5.1% annually between 2021 and 2030, reaching a total of nearly $6.8 trillion. Additionally, it is anticipated that from 2021 to 2030, Medicare spending is going to rise at a 7.2% annual pace while Medicaid spending will rise at a 5.6% annual rate. Therefore, the rise in healthcare expenditures is driving the growth of the drug repositioning service industry.

Who Are The Major Players In The Global Drug Repositioning Service Market?

Major companies operating in the drug repositioning service market are Recursion Pharmaceuticals Inc., Excelra, LifeArc, Cosmos Health Inc., Fios Genomics, Insilico Medicine Inc., Melior Discovery, Delta4, Acubiosys, VeriSIM Life, BioXcel Therapeutics Inc., Pharnext S.S., NuMedii, GVK Biosciences, Plex Research, Paradigm Biopharmaceuticals, BenevolentAI Limited

What Are The Key Trends Of The Global Drug Repositioning Service Market? AI-Enabled Drug Repositioning Project

Major companies operating in the drug repositioning service market are focusing on the adoption of artificial intelligence (AI) in drug repositioning, such as computational drug repositioning systems, which systematically identify new therapeutic indications for existing drugs using AI-driven analysis of literature and biological data. A computational drug repositioning system refers to a technology-driven platform that uses artificial intelligence, machine learning, and data mining to systematically analyze existing drugs, compounds, and biological data. For instance, in Nov 2024, UBE and FRONTEO, Japanese-based companies, launched a co-creation project. The co-creation project offers a collaborative framework that integrates expertise from both UBE and FRONTEO to enhance drug repositioning efforts. It enables seamless interaction between dry research (data analysis) and wet research (biological testing), improving the transition from hypothesis generation to experimental validation. By leveraging FRONTEO’s AI-driven Drug Discovery AI Factory and KIBIT technology, the project systematically discovers unreported relationships between diseases and molecules.

Need data on a specific region in this market?

Request Customisation

What Are Latest Mergers And Acquisitions In The Drug Repositioning Service Market? Cosmos Health Acquires Cloudscreen To Boost AI-Driven Drug Repurposing With Cloudpharm

In January 2024, Cosmos Health Inc., a US-based healthcare group, acquired the Cloudscreen platform for Cloudpharm P.C. for an undisclosed amount. With this acquisition, Cosmos Health Inc. aims to accelerate drug repurposing efforts by leveraging Cloudscreen’s AI platform to identify new therapeutic uses for existing drugs more efficiently. Cloudpharm P.C. is a Greece-based company that offers drug repositioning services.

What Is The Regional Outlook For The Global Drug Repositioning Service Market?

North America was the largest region in the drug repositioning service market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the the drug repositioning service market market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the drug repositioning service market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Drug Repositioning Service Market?

The drug repositioning service market consists of revenues earned by entities by providing services such as target validation, pharmacovigilance support, formulation optimization, drug combination analysis, and post-marketing surveillance. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Drug Repositioning Service Industry?

The drug repositioning service market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the drug repositioning service industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

1. Executive Summary

2. Drug Repositioning Service Market Characteristics

3. Drug Repositioning Service Market Trends And Strategies

4. Drug Repositioning Service Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Drug Repositioning Service Growth Analysis And Strategic Analysis Framework

5.1. Global Drug Repositioning Service PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Drug Repositioning Service Market Growth Rate Analysis

5.4. Global Drug Repositioning Service Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Drug Repositioning Service Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Drug Repositioning Service Total Addressable Market (TAM)

6. Drug Repositioning Service Market Segmentation

6.1. Global Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Generic Drugs

Clinical Trial Failed Drugs

6.2. Global Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oncology

Neurology

Infectious Diseases

Cardiovascular Diseases

Other Therapeutic Areas

6.3. Global Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pharmaceutical Companies

Biotechnology Firms

Contract Research Organizations (Cros)

Academic Research Institutions

Hospitals And Ambulatory Surgical Centers

6.4. Global Drug Repositioning Service Market, Sub-Segmentation Of Generic Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Small Molecule Drugs

Biologics

Biosimilars

Peptide-Based Drugs

6.5. Global Drug Repositioning Service Market, Sub-Segmentation Of Clinical Trial Failed Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Phase I Failed Drugs

Phase II Failed Drugs

Phase III Failed Drugs

Safety-Related Failed Drugs

Efficacy-Related Failed Drugs

7. Drug Repositioning Service Market Regional And Country Analysis

7.1. Global Drug Repositioning Service Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Drug Repositioning Service Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Drug Repositioning Service Market

8.1. Asia-Pacific Drug Repositioning Service Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Drug Repositioning Service Market

9.1. China Drug Repositioning Service Market Overview

9.2. China Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Drug Repositioning Service Market

10.1. India Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Drug Repositioning Service Market

11.1. Japan Drug Repositioning Service Market Overview

11.2. Japan Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Drug Repositioning Service Market

12.1. Australia Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Drug Repositioning Service Market

13.1. Indonesia Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Drug Repositioning Service Market

14.1. South Korea Drug Repositioning Service Market Overview

14.2. South Korea Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Drug Repositioning Service Market

15.1. Western Europe Drug Repositioning Service Market Overview

15.2. Western Europe Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Drug Repositioning Service Market

16.1. UK Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Drug Repositioning Service Market

17.1. Germany Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Drug Repositioning Service Market

18.1. France Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Drug Repositioning Service Market

19.1. Italy Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Drug Repositioning Service Market

20.1. Spain Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Drug Repositioning Service Market

21.1. Eastern Europe Drug Repositioning Service Market Overview

21.2. Eastern Europe Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Drug Repositioning Service Market

22.1. Russia Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Drug Repositioning Service Market

23.1. North America Drug Repositioning Service Market Overview

23.2. North America Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Drug Repositioning Service Market

24.1. USA Drug Repositioning Service Market Overview

24.2. USA Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Drug Repositioning Service Market

25.1. Canada Drug Repositioning Service Market Overview

25.2. Canada Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Drug Repositioning Service Market

26.1. South America Drug Repositioning Service Market Overview

26.2. South America Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Drug Repositioning Service Market

27.1. Brazil Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Drug Repositioning Service Market

28.1. Middle East Drug Repositioning Service Market Overview

28.2. Middle East Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Drug Repositioning Service Market

29.1. Africa Drug Repositioning Service Market Overview

29.2. Africa Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Drug Repositioning Service Market Competitive Landscape And Company Profiles

30.1. Drug Repositioning Service Market Competitive Landscape

30.2. Drug Repositioning Service Market Company Profiles

30.2.1. Recursion Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Excelra Overview, Products and Services, Strategy and Financial Analysis

30.2.3. LifeArc Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Cosmos Health Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Fios Genomics Overview, Products and Services, Strategy and Financial Analysis

31. Drug Repositioning Service Market Other Major And Innovative Companies

31.1. Insilico Medicine Inc.

31.2. Melior Discovery

31.3. Delta4

31.4. Acubiosys

31.5. VeriSIM Life

31.6. BioXcel Therapeutics Inc.

31.7. Pharnext S.S.

31.8. NuMedii

31.9. GVK Biosciences

31.10. Plex Research

31.11. Paradigm Biopharmaceuticals

31.12. BenevolentAI Limited

31.13. 0

31.14. 0

31.15. 0

32. Global Drug Repositioning Service Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Drug Repositioning Service Market

34. Recent Developments In The Drug Repositioning Service Market

35. Drug Repositioning Service Market High Potential Countries, Segments and Strategies

35.1 Drug Repositioning Service Market In 2029 - Countries Offering Most New Opportunities

35.2 Drug Repositioning Service Market In 2029 - Segments Offering Most New Opportunities

35.3 Drug Repositioning Service Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Drug Repositioning Service Market, Sub-Segmentation Of Generic Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Drug Repositioning Service Market, Sub-Segmentation Of Clinical Trial Failed Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Drug Repositioning Service Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Drug Repositioning Service Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Asia-Pacific, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Asia-Pacific, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: China, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: China, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: India, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: India, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: Japan, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: Japan, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Australia, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Australia, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Indonesia, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Indonesia, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: South Korea, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: South Korea, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: Western Europe, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Western Europe, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: UK, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: UK, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: Germany, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Germany, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: France, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: France, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: Italy, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: Italy, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Spain, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Spain, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Eastern Europe, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Eastern Europe, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Russia, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Russia, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: North America, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: North America, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: USA, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: USA, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: Canada, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: Canada, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: South America, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: South America, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: Brazil, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: Brazil, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Middle East, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Middle East, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Africa, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Africa, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Recursion Pharmaceuticals Inc. Financial Performance

Table 77: Excelra Financial Performance

Table 78: LifeArc Financial Performance

Table 79: Cosmos Health Inc. Financial Performance

Table 80: Fios Genomics Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Drug Repositioning Service Market, Sub-Segmentation Of Generic Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Drug Repositioning Service Market, Sub-Segmentation Of Clinical Trial Failed Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Drug Repositioning Service Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Drug Repositioning Service Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Asia-Pacific, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Asia-Pacific, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: China, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: China, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: India, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: India, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: Japan, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: Japan, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Australia, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Australia, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Indonesia, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Indonesia, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: South Korea, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: South Korea, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: Western Europe, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Western Europe, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: UK, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: UK, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: Germany, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Germany, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: France, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: France, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: Italy, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: Italy, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Spain, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Spain, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Eastern Europe, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Eastern Europe, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Russia, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Russia, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: North America, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: North America, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: USA, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: USA, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: Canada, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: Canada, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: South America, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: South America, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: Brazil, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: Brazil, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Middle East, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Middle East, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Africa, Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Africa, Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Recursion Pharmaceuticals Inc. Financial Performance

Figure 77: Excelra Financial Performance

Figure 78: LifeArc Financial Performance

Figure 79: Cosmos Health Inc. Financial Performance

Figure 80: Fios Genomics Financial Performance

Strategic Growth Drivers Shaping the Nutraceutical Excipients Market Outlook 2025- 2034:The Role Of Health And Wellness In Driving Growth In The Nutraceutical Excipients Market

Emerging Growth Drivers in the Opioids Market Landscape: Growing Surgical Procedures Fueling Demand In The Opioids Market

Osimertinib Drugs Market Outlook 2025–2034: Identifying Growth Drivers, Technology Trends, and Policy Impact

Otic Drugs Market Insights: In-Depth Look at Growth Trends, Market Size, and Opportunities for 2025-2034

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Uncover TBRC’s strategic outlook on technological trends, regulatory factors, and market growth in transdermal drug delivery systems.

Explore forecast data, therapeutic advancements, and pipeline progress in TBRC’s Tuberous Sclerosis Drug Market report.

Non-Emergency Medical Transportation Market 2024 – By Type (Courier Services, Insurance Backed Patient Transportation, Private Pay Patient Transportation.), By Application (Dialysis, Routine Doctor Visits, Mental Health-...

View Report

Well Testing Services Global Market Report 2025 – By Services Type( Downhole Well Testing, Surface Well Testing, Reservoir Sampling, Real Time Well Testing), By Product Type( Horizontal Wells, Vertical Wells), By Applica...

View Report

48 Volt Battery System Global Market Report 2025 – By Component (Alternating Current (Ac) Or Direct Current (Dc) Inverter, 48-Volt Lithium-Ion Battery, Battery Controller, Power Distribution Box, Other Components), By Ar...

View Report

Train Seat Global Market Report 2025 – By Train (Regional Or Intercity, High-Speed, Metro, Light), By Product (Non-Recliner, Luxury Or Premium, Recliner, Subway Seats, Sleeper Or Couchette), By End-User (Original Equipme...

View Report

OEM Insulation Global Market Report 2025 – By Insulation Type( Blankets, Rolls and Batts, Loose Fill, Other Insulation Types ), By Material Type( Mineral Wool, Polyurethane Foam (PUF), Flexible Elastomeric Foam (FEF), Ot...

View Report

Healthcare Mobility Solutions Global Market Report 2025 – By Product type (Mobile Devices, Mobile Applications, Enterprise mobility platforms, Other Product Types), By Applications (Enterprise Solutions, mHealth Applicat...

View Report

Compound Feed Global Market Report 2025 – By Ingredient (Cereals, Cakes and Meals, Byproducts, Supplements), By Form (Solid, Liquid), By Source (Plant Based, Animal Based), By Animal Type (Cattle, Swine, Poultry, Aquacul...

View Report

Pharmacies and Drug Stores Global Market Report 2025 – By Drug Type (Prescription Drugs, OTC drugs), By Type (Community Pharmacy, Hospital Pharmacy, Clinical Pharmacy, Industrial Pharmacy, Compounding Pharmacy, Consultin...

View Report

Frequently Asked Questions

What is the definition of the Drug Repositioning Service market?

Drug repositioning service involves systematically identifying new therapeutic uses for existing drugs, which allows pharmaceutical companies to maximize the value of their existing drug portfolios while minimizing the risks associated with developing entirely new compounds. Drug repositioning service leveraging existing clinical data and research, these services help streamline the drug development process, significantly reducing the time and cost required to bring effective treatments to patients. The main types of drug repositioning service are generic drugs, and clinical trial failed drugs. Generic drugs are medications that have the same active ingredients, strength, dosage form, and therapeutic effect as brand-name drugs but are typically sold at lower prices. The various therapeutic area include oncology, neurology, infectious diseases, cardiovascular diseases, other therapeutic area. These are used by various end users such as pharmaceutical companies, biotechnology firms, contract research organizations (CROs), academic research institutions, hospitals and ambulatory surgical centers. For further insights on this market, request a sample here

How will the Drug Repositioning Service market drivers and restraints affect the market dynamics? What forces will shape the Drug Repositioning Service industry going forward?

The market major growth driver - Surge In Rise In Healthcare Expenditures Fueling The Growth Of The Market Due To Increasing Medical Costs. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Drug Repositioning Service market?

The drug repositioning service market size has grown strongly in recent years. It will grow from $32.34 billion in 2024 to $34.2 billion in 2025 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to high attrition rates in traditional drug development, regulatory incentives such as orphan drug designation and fast-track approvals, advancements in computational biology and AI, rising healthcare costs, availability of extensive clinical data from existing drugs. The drug repositioning service market size is expected to see strong growth in the next few years. It will grow to $43.26 billion in 2029 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to Increasing prevalence of chronic and complex diseases, continued advancements in AI and machine learning, growing focus on personalized medicine, expansion of global healthcare access, strengthening of intellectual property protections for repurposed drugs, collaborations between pharmaceutical companies and research institutions. Major trends in the forecast period include rising demand for cost-effective drug development, expansion of data-driven repurposing platforms, focus on rare and complex diseases, steady market growth across major regions, regulatory support for repositioning strategies, and increasing investment in predictive analytics and real-world data integration. For further insights on this market, request a sample here

How is the Drug Repositioning Service market segmented?

The drug repositioning servicemarket covered in this report is segmented –
1) By Type: Generic Drugs, Clinical Trial Failed Drugs
2) By Therapeutic Area: Oncology, Neurology, Infectious Diseases, Cardiovascular Diseases, Other Therapeutic Area
3) By End-User: Pharmaceutical Companies, Biotechnology Firms, Contract Research Organizations (CROs), Academic Research Institutions, Hospitals And Ambulatory Surgical Centers. Subsegments:
1) By Generic Drugs: Small Molecule Drugs, Biologics, Biosimilars, Peptide-Based Drugs
2) By Clinical Trial Failed Drugs: Phase I Failed Drugs, Phase II Failed Drugs, Phase III Failed Drugs, Safety-Related Failed Drugs, Efficacy-Related Failed Drugs. For further insights on this market, request a sample here

Which region has the largest share of the Drug Repositioning Service market? What are the other regions covered in the report?

Who are the major players in the Drug Repositioning Service market?

What are the key trends in the Drug Repositioning Service market?

Major trends in this market include AI-Enabled Drug Repositioning Project. For further insights on this market, request a sample here.

Book your 30 minutes free consultation with our research experts

Drug Repositioning Service Global Market Report 2025

Drug Repositioning Service Market Overview

What Is Covered Under Drug Repositioning Service Market?

What Is The Drug Repositioning Service Market Growth Forecast?

What Is The Drug Repositioning Service Market Size 2025 And Growth Rate?

What’s The Trade War Impact On Pharmaceuticals Industry?

How Is The Drug Repositioning Service Market Segmented?

What Is Driving The Drug Repositioning Service Market? Surge In Rise In Healthcare Expenditures Fueling The Growth Of The Market Due To Increasing Medical Costs

Who Are The Major Players In The Global Drug Repositioning Service Market?

What Are The Key Trends Of The Global Drug Repositioning Service Market? AI-Enabled Drug Repositioning Project

What Are Latest Mergers And Acquisitions In The Drug Repositioning Service Market? Cosmos Health Acquires Cloudscreen To Boost AI-Driven Drug Repurposing With Cloudpharm

What Is The Regional Outlook For The Global Drug Repositioning Service Market?

What Defines the Drug Repositioning Service Market?

How is Market Value Defined and Measured?

What is the Market Assessment and Strategic Outlook for the Drug Repositioning Service Industry?

Table Of Contents

List Of Tables

List Of Figures

Frequently Asked Questions